|
TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Innate Pharma; Merck Serono |
Research Funding - Bristol-Myers Squibb (Inst); MERCK SERONO (Inst) |
|
|
Honoraria - AstraZeneca; Biogen; Bristol-Myers Squibb; Innate Pharma; Merck Serono; Merck Sharp & Dohme |
Consulting or Advisory Role - AstraZeneca; BIOGEN; Bristol-Myers Squibb; Innate Pharma; Merck Serono; Merck Sharp & Dohme |
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck KGaA; MSD; Nanobiotix; Roche |
Speakers' Bureau - Bristol-Myers Squibb; Merck KGaA |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck KGaA; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Serono |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD Oncology |
Travel, Accommodations, Expenses - Ipsen; Janssen Oncology; MSD Oncology |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Merck |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Merck; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Innate Pharma; Merck Serono; Merck Sharp & Dome |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Serono |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech |
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer |
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck Serono; MSD Oncology; Novartis |
Research Funding - AstraZeneca/MedImmune (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Merck Serono; MSD Oncology |
|
|
No Relationships to Disclose |